Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Ophthalmology

The Path to Healing: Standard Treatment & Medications

At a Glance

Idiopathic scleritis treatment usually starts with oral anti-inflammatory medicine for milder disease and may progress to prednisone, immune-suppressing medicines, or biologics for severe or recurring inflammation. Doctors monitor eye findings, pain, medication risks, and steroid dose.

Because idiopathic scleritis is often presumed to be an immune-mediated condition, the goal of treatment is to “calm” the overactive immune response before it can damage the structure of the eye [1]. Doctors tailor treatment based on severity and response, often beginning with milder systemic treatments and moving to more powerful medications if the inflammation persists, returns, or is highly sight-threatening [2][3].

Step 1: Oral NSAIDs (For Mild to Moderate Disease)

For many patients with diffuse or nodular non-necrotizing scleritis, an initial line of defense is oral nonsteroidal anti-inflammatory drugs (NSAIDs), such as indomethacin or naproxen [2][3].

  • How they work: These medications block the enzymes that create the chemical signals for pain and swelling [2].
  • What to expect: Unlike the drops used for simple “red eye,” these are systemic pills that work throughout the body. While they can be effective, they may take time to reach full effect. Your doctor will weigh the risks of gastrointestinal bleeding/ulcers, kidney damage, cardiovascular issues, and pregnancy considerations, and monitor you accordingly [3].

Step 2: Systemic Corticosteroids (For Rapid Control)

If NSAIDs are not enough, or if you present with a more aggressive form like rapidly progressive, posterior, or vision-threatening scleritis, your doctor will likely move to systemic corticosteroids (such as prednisone) [4][5].

  • The Goal: Steroids are highly effective at quickly stopping active inflammation to prevent vision loss [4].
  • The Taper and Safety: Never stop prednisone abruptly, as this can cause severe health complications. Steroids are generally not intended for long-term use at high doses due to side effects. Your doctor will slowly “taper” (lower) your dose as the eye improves [6]. Monitoring includes checking for infection risk, blood sugar changes, blood pressure changes, mood/sleep effects, and bone protection [7][3]. If the inflammation flares back up during this taper, it is a signal that a different approach is needed [6].

Step 3: Steroid-Sparing Agents (For Long-term Control)

If your scleritis is refractory (doesn’t respond to steroids) or recurrent (keeps coming back), or if you cannot tolerate the side effects of steroids, your doctor may introduce conventional immunomodulators [6][3]. These are often called “steroid-sparing” agents because they allow you to lower or stop your steroid dose while keeping the eye calm.

  • Methotrexate: This is one of the most common options. In small observational cohorts, a large majority of patients achieved inflammation control within a year of starting methotrexate [6][7].
  • Other Options: Your doctor might also consider medications like Mycophenolate Mofetil (CellCept) or Azathioprine [8]. These medications require several weeks or months to reach full effectiveness. They require strict compliance with regular blood tests to monitor your liver and blood counts, as well as counseling regarding infection risk and pregnancy [6][7].

Step 4: Biologics and Advanced Therapies

For the most severe cases—such as severe necrotizing disease, or cases that have failed conventional treatments—doctors may use biologics [9][5]. (Note: these are generally used off-label for scleritis).

  • TNF Inhibitors: Medications like adalimumab or infliximab target specific proteins in the immune system [5][8].
  • Rituximab: This biologic targets the B-cells of the immune system. In a small observational study of 15 patients with refractory scleritis, 14 showed clinical improvement after treatment with rituximab [9].
  • Other Agents: For severe vasculitic necrotizing disease, agents like cyclophosphamide may be used under specialist care.

Monitoring Your Progress

Treatment success is not just about how well you can see. Your doctor will use clinical exams and imaging to measure:

  1. Redness and Inflammation: Is the deep-red or purple color fading? [9][10]
  2. Scleral Thickness: Using imaging like Ultrasound Biomicroscopy (UBM) or OCT, doctors can objectively measure if the swelling inside the eye wall is decreasing [11].
  3. Pain: A decrease in the deep, boring ache is often the first sign that a treatment is working [9].
  4. Steroid Load: A major goal is being able to control the disease using a minimal dose of steroids or none at all [6][7].

Important Note: Never start, stop, or taper these medicines without your prescriber’s instructions, and never self-treat with over-the-counter redness-relief drops. Before starting systemic treatments, your doctor will consider whether an infection is present, as using steroids or immunosuppressants on an infected eye can worsen the infection [12][4][13].

Common questions in this guide

What medicine is usually tried first for mild idiopathic scleritis?
For mild to moderate diffuse or nodular non-necrotizing idiopathic scleritis, doctors often start with an oral NSAID such as indomethacin or naproxen. These medicines work throughout the body and may take time to reach their full effect. Your clinician should review stomach, kidney, heart, and pregnancy-related risks before prescribing one.
When are prednisone or other steroids used for scleritis?
Prednisone or another systemic corticosteroid may be used when an NSAID is not enough or when scleritis is rapidly progressive, posterior, or threatens vision. Steroids can calm inflammation quickly, but the dose usually needs a gradual taper. Do not stop prednisone suddenly unless your prescriber tells you to.
What are steroid-sparing medicines, and when might I need one?
Steroid-sparing medicines are used when scleritis keeps returning, does not respond adequately to steroids, or steroid side effects are a concern. Options may include methotrexate, mycophenolate mofetil, and azathioprine. They can take weeks or months to work and require regular blood tests.
Are biologic medicines used to treat severe scleritis?
Biologics may be considered for severe necrotizing scleritis or disease that has not responded to conventional immune-suppressing treatment. Examples include adalimumab, infliximab, and rituximab, and these medicines are generally used off-label for scleritis. Treatment should be directed by a specialist because infection and other risks need close monitoring.
How will my doctor know whether scleritis treatment is working?
Doctors judge improvement by more than vision alone. They may look for less deep eye pain and redness, measure scleral thickness with imaging such as ultrasound biomicroscopy or OCT, and assess whether the steroid dose can be reduced. Ongoing exams and tests help balance inflammation control with medication safety.
What should I avoid while taking medicine for idiopathic scleritis?
Do not start, stop, or taper scleritis medicines without the prescriber's instructions, and do not self-treat with over-the-counter redness-relief drops. Before immune-suppressing treatment begins, doctors should consider whether an infection is present because steroids or immune-suppressing medicines can worsen an infection. Ask which vaccinations and monitoring tests are appropriate before treatment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my subtype (diffuse, nodular, etc.), is starting with an NSAID appropriate, or is my case severe enough to require corticosteroids immediately?
  2. 2.If we start with prednisone, what is the 'taper' schedule, and at what point would we consider moving to a steroid-sparing agent like methotrexate?
  3. 3.How will you monitor me for the side effects of these stronger medications, such as changes in my blood counts, liver function, or bone density?
  4. 4.What clinical signs are you using to determine if my treatment is working?
  5. 5.Are my vaccinations up to date, and are there any I should receive before we potentially start a biologic or immunosuppressant?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    [Diagnostic and Therapeutic Management of Episcleritis and Scleritis].

    Turgut F, Dingerkus V, Tappeiner C, Becker M

    Klinische Monatsblatter fur Augenheilkunde 2023; (240(5)):725-738 doi:10.1055/a-2022-0689.

    PMID: 36827997
  2. 2

    Management of noninfectious scleritis.

    Abdel-Aty A, Gupta A, Del Priore L, Kombo N

    Therapeutic advances in ophthalmology 2022; (14()):25158414211070879 doi:10.1177/25158414211070879.

    PMID: 35083421
  3. 3

    Current Approach for the Diagnosis and Management of Noninfective Scleritis.

    Dutta Majumder P, Agrawal R, McCluskey P, Biswas J

    Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 2020; (10(2)):212-223 doi:10.1097/APO.0000000000000341.

    PMID: 33290287
  4. 4

    Nodular syphilitic scleritis masquerading as an ocular tumor.

    Shaikh SI, Biswas J, Rishi P

    Journal of ophthalmic inflammation and infection 2015; (5()):8 doi:10.1186/s12348-015-0040-5.

    PMID: 25861399
  5. 5

    Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

    Sota J, Girolamo MM, Frediani B, et al.

    Ophthalmology and therapy 2021; (10(4)):777-813 doi:10.1007/s40123-021-00393-8.

    PMID: 34476773
  6. 6

    Methotrexate for the treatment of noninfectious scleritis.

    Sands DS, Chan SCY, Gottlieb CC

    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2018; (53(4)):349-353 doi:10.1016/j.jcjo.2017.11.009.

    PMID: 30119788
  7. 7

    Clinical characteristics and efficacy of methotrexate in Japanese patients with noninfectious scleritis.

    Hiyama T, Harada Y, Kiuchi Y

    Japanese journal of ophthalmology 2021; (65(1)):97-106 doi:10.1007/s10384-020-00778-5.

    PMID: 33107015
  8. 8

    Scleritis associated with relapsing polychondritis.

    Sainz-de-la-Maza M, Molina N, Gonzalez-Gonzalez LA, et al.

    The British journal of ophthalmology 2016; (100(9)):1290-4 doi:10.1136/bjophthalmol-2015-306902.

    PMID: 26888976
  9. 9

    Rituximab in the Treatment of Refractory Noninfectious Scleritis.

    Cao JH, Oray M, Cocho L, Foster CS

    American journal of ophthalmology 2016; (164()):22-8.

    PMID: 26766304
  10. 10

    New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.

    Fabiani C, Sota J, Sainz-de-la-Maza M, et al.

    Mediators of inflammation 2020; (2020()):8294560 doi:10.1155/2020/8294560.

    PMID: 32410867
  11. 11

    Morphometric Assessment of Sclera and Ciliary Body in Patients with Noninfectious Anterior Scleritis: A Quantitative Study Using Ultrasound Biomicroscopy.

    Liu T, Ma G, Xu W, et al.

    Ocular immunology and inflammation 2024; (32(9)):2000-2007 doi:10.1080/09273948.2024.2315189.

    PMID: 38376887
  12. 12

    Scleritis: Differentiating infectious from non-infectious entities.

    Murthy SI, Sabhapandit S, Balamurugan S, et al.

    Indian journal of ophthalmology 2020; (68(9)):1818-1828 doi:10.4103/ijo.IJO_2032_20.

    PMID: 32823398
  13. 13

    Occult Fungal Scleritis.

    Jeang LJ, Davis A, Madow B, et al.

    Ocular oncology and pathology 2017; (3(1)):41-44 doi:10.1159/000449103.

    PMID: 28275602

This page is for informational purposes only and does not constitute medical advice. Your eye specialist should choose, monitor, and taper idiopathic scleritis treatment based on your specific situation.

Get notified when new evidence is published on Idiopathic scleritis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.